Follow
Richard Neubig
Title
Cited by
Cited by
Year
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology
RR Neubig, M Spedding, T Kenakin, A Christopoulos
Pharmacological reviews 55 (4), 597-606, 2003
7972003
International Union of Pharmacology. XLVI. G protein-coupled receptor list
SM Foord, TI Bonner, RR Neubig, EM Rosser, JP Pin, AP Davenport, ...
Pharmacological reviews 57 (2), 279-288, 2005
7962005
Phagocyte-derived catecholamines enhance acute inflammatory injury
MA Flierl, D Rittirsch, BA Nadeau, AJ Chen, JV Sarma, FS Zetoune, ...
Nature 449 (7163), 721-725, 2007
5022007
Regulators of G-protein signalling as new central nervous system drug targets
RR Neubig, DP Siderovski
Nature Reviews Drug Discovery 1 (3), 187-197, 2002
4952002
The highly conserved DRY motif of class AG protein-coupled receptors: beyond the ground state
GE Rovati, V Capra, RR Neubig
Molecular pharmacology 71 (4), 959-964, 2007
4762007
Membrane organization in G‐protein mechanisms
RR Neubig
The FASEB Journal 8 (12), 939-946, 1994
4631994
Acetylcholine and local anesthetic binding to Torpedo nicotinic postsynaptic membranes after removal of nonreceptor peptides.
RR Neubig, EK Krodel, ND Boyd, JB Cohen
Proceedings of the National Academy of Sciences 76 (2), 690-694, 1979
4341979
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands
AP Davenport, SPH Alexander, JL Sharman, AJ Pawson, HE Benson, ...
Pharmacological reviews 65 (3), 967-986, 2013
3362013
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers
JP Pin, R Neubig, M Bouvier, L Devi, M Filizola, JA Javitch, MJ Lohse, ...
Pharmacological reviews 59 (1), 5-13, 2007
3312007
Equilibrium binding of [3H] tubocurarine and [3H] acetylcholine by Torpedo postsynaptic membranes: stoichiometry and ligand interactions
RR Neubig, JB Cohen
Biochemistry 18 (24), 5464-5475, 1979
2971979
International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function
AP Davenport, TI Bonner, SM Foord, AJ Harmar, RR Neubig, JP Pin, ...
Pharmacological reviews 57 (4), 541-546, 2005
2882005
IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels
AJ Harmar, RA Hills, EM Rosser, M Jones, OP Buneman, DR Dunbar, ...
Nucleic acids research 37 (suppl_1), D680-D685, 2009
2742009
Structure of Gαq-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs
S Lutz, A Shankaranarayanan, C Coco, M Ridilla, MR Nance, C Vettel, ...
Science 318 (5858), 1923-1927, 2007
2692007
Regulator of G protein signaling proteins: novel multifunctional drug targets
H Zhong, RR Neubig
Journal of Pharmacology and Experimental Therapeutics 297 (3), 837-845, 2001
2512001
CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling
CR Evelyn, SM Wade, Q Wang, M Wu, JA Iñiguez-Lluhí, SD Merajver, ...
Molecular cancer therapeutics 6 (8), 2249-2260, 2007
2452007
International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands
A Christopoulos, JP Changeux, WA Catterall, D Fabbro, TP Burris, ...
Pharmacological reviews 66 (4), 918-947, 2014
2252014
M4 muscarinic receptor signaling ameliorates striatal plasticity deficits in models of L-DOPA-induced dyskinesia
W Shen, JL Plotkin, V Francardo, WKD Ko, Z Xie, Q Li, T Fieblinger, ...
Neuron 88 (4), 762-773, 2015
2242015
Small molecule protein–protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles
LL Blazer, RR Neubig
Neuropsychopharmacology 34 (1), 126-141, 2009
2242009
Permeability control by cholinergic receptors in Torpedo postsynaptic membranes: agonist dose-response relations measured at second and millisecond times
RR Neubig, JB Cohen
Biochemistry 19 (12), 2770-2779, 1980
2231980
Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β–induced fibrogenesis in human colonic myofibroblasts
LA Johnson, ES Rodansky, AJ Haak, SD Larsen, RR Neubig, ...
Inflammatory bowel diseases 20 (1), 154-165, 2014
1982014
The system can't perform the operation now. Try again later.
Articles 1–20